JY
RVMD icon

Jeff Yass’s Revolution Medicines RVMD Stock Holding History

Jeff Yass’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$126M Sell
674,000
-345,200
-34% -$50.4M 0.01% 816
2026
Q1 		$99.1M Buy
1,019,200
+859,100
+537% +$86.7M 0.01% 837
2025
Q4 		$12.8M Sell
160,100
-68,200
-30% -$4.47M ﹤0.01% 2735
2025
Q3 		$10.7M Buy
228,300
+114,900
+101% +$4.5M ﹤0.01% 2959
2025
Q2 		$4.17M Sell
113,400
-18,200
-14% -$699K ﹤0.01% 4317
2025
Q1 		$4.65M Sell
131,600
-87,600
-40% -$3.56M ﹤0.01% 3783
2024
Q4 		$9.59M Buy
219,200
+8,200
+4% +$414K ﹤0.01% 2719
2024
Q3 		$9.57M Buy
211,000
+120,300
+133% +$5.24M ﹤0.01% 2673
2024
Q2 		$3.52M Buy
90,700
+45,300
+100% +$1.69M ﹤0.01% 4024
2024
Q1 		$1.46M Sell
45,400
-19,900
-30% -$590K ﹤0.01% 6064
2023
Q4 		$1.87M Sell
65,300
-2,500
-4% -$60.1K ﹤0.01% 5503
2023
Q3 		$1.88M Buy
67,800
+32,800
+94% +$973K ﹤0.01% 5262
2023
Q2 		$936K Buy
35,000
+8,400
+32% +$206K ﹤0.01% 6841
2023
Q1 		$576K Buy
26,600
+500
+2% +$12.3K ﹤0.01% 8221
2022
Q4 		$622K Buy
+26,100
New +$555K ﹤0.01% 7306
2022
Q2 		– Sell
-19,500
Closed -$497K – 13805
2022
Q1 		$497K Sell
19,500
-17,400
-47% -$379K ﹤0.01% 8999
2021
Q4 		$929K Sell
36,900
-2,200
-6% -$62K ﹤0.01% 7502
2021
Q3 		$1.08M Buy
39,100
+5,900
+18% +$172K ﹤0.01% 7365
2021
Q2 		$1.05M Buy
33,200
+24,400
+277% +$852K ﹤0.01% 7624
2021
Q1 		$404K Buy
+8,800
New +$395K ﹤0.01% 9966

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jeff Yass's RVMD Position: Q2 2026 in Review

Jeff Yass increased its Revolution Medicines (RVMD) stake by 344% in Q2 2026, buying an estimated $25.8M and bringing the position to 227,985 shares worth $42.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1667.

Jeff Yass first reported a position in RVMD in Q1 2020 and has held it in 25 quarters since. 689 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Jeff Yass held 227,985 shares of Revolution Medicines worth $42.7M as of Q2 2026.
  • Jeff Yass bought 176,600 Revolution Medicines shares in Q2 2026, an estimated $25.8M.
  • Revolution Medicines made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #1667 holding.
  • Jeff Yass first reported a position in Revolution Medicines in Q1 2020 and has held it in 25 quarters since.
  • 689 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.